Skip To Content

Biobank (Cancer tissue bank)

Biobank (Cancer tissue bank)

Background of Establishment

- Increasing demand for high-quality, certified human biosources

- The emerging need for systematic sample management

- Availability of human biosources for any researcher

- Resolution of ethical issues when using human biosources 



We contribute to the growth of clinical and basic medical research by storing and managing human resources and related clinical information and providing them ethically and fairly.

Sample Type

Fresh frozen tissue Tumor / Normal (unit: vial, storage: Liquid Nitrogen -196℃)



Colon and Rectum


Endocrine system

Thyroid, Adrenal gland

Female genitals organs

Uterus, Ovary

Gastrointestinal tract

Stomach, Esophagus, Small intestine

Head and Neck

Oral cavity, Larynx, Pharynx, Tonsil, Salivary gland


Liver, Pancreas, AoV, Bile duct, Gallbladder

Male genital organs

Prostate, Testis

Nervous system


Skin and Soft tissue


Urinary tracts

Kidney, Ureter, Bladder, Urethra


Lung, Thymus, Lymph node, Aortic valve, Spleen, Tendon, Placenta


- Bank Manager: Pathology Professor Lee Hye Seung

- Information management and security Pathology Professor Kwak Yoonjin

- Steering committee (subcommittee by organ)

- Researcher for the management of human biosources


Task Overview

- Informed consent (Bioehtics and safety ace enforcement rule ‘Annexed form41’)
- Collection tissue samples (No disturbance of the patient treatments)
- Ischemic time management (Banking within the shortest time and freezing in LN2)
- Real time temperature monitoring on LN2 tank
- Clinical/epidemiological information management
- Regular quality assessment of resources (DNA, RNA purity, Tissue morphology review)
- Resource distribution after approval by subcommittee

  After distribution, management of research


☎ 02-2072-2192



(Seoul National University Hospital Biomedical Research Institute-BIOBANK–Cancer Tissue Bank)

전체 메뉴

전체 검색

전체 검색